{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:06:41Z","timestamp":1788887201053,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570034"],"award-info":[{"award-number":["81570034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870036"],"award-info":[{"award-number":["81870036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["1804h08020237"],"award-info":[{"award-number":["1804h08020237"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.biopha.2019.109652","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T18:22:54Z","timestamp":1573755774000},"page":"109652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"121","author":[{"given":"Shuang","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Long","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-He","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2019.109652_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"47","key":"10.1016\/j.biopha.2019.109652_bib0010","doi-asserted-by":"crossref","first-page":"81813","DOI":"10.18632\/oncotarget.17850","article-title":"Role of the inflammasome in chronic obstructive pulmonary disease (COPD)","volume":"8","author":"Colarusso","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2019.109652_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/138161207779313777","article-title":"Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations","volume":"13","author":"Mallia","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2019.109652_bib0020","first-page":"2257","article-title":"Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test","volume":"10","author":"Dai","year":"2015","journal-title":"Int. J. Chronic. Obstr"},{"issue":"3","key":"10.1016\/j.biopha.2019.109652_bib0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2014.11.020","article-title":"Neuraminidase inhibitors: who, when, where?","volume":"21","author":"Nguyen-Van-Tam","year":"2015","journal-title":"Clin. Microbiol. Infec."},{"issue":"12","key":"10.1016\/j.biopha.2019.109652_bib0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1473-3099(17)30537-6","article-title":"Finding the right combination antiviral therapy for influenza","volume":"17","author":"Ison","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2019.109652_bib0035","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/344237","article-title":"Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene","volume":"186","author":"Abed","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2019.109652_bib0040","doi-asserted-by":"crossref","first-page":"j2841","DOI":"10.1136\/bmj.j2841","article-title":"WHO downgrades oseltamivir on drugs list after reviewing evidence","volume":"357","author":"Kmietowicz","year":"2017","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.biopha.2019.109652_bib0045","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/CAD.0b013e3283651862","article-title":"Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180","volume":"24","author":"Lin","year":"2013","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2019.109652_bib0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.intimp.2015.07.011","article-title":"Forsythiaside inhibits cigarette smoke-induced lung inflammation by activation of Nrf2 and inhibition of NF-kappaB","volume":"28","author":"Cheng","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2019.109652_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.resp.2015.05.006","article-title":"Emodin mitigates diesel exhaust particles-induced increase in airway resistance, inflammation and oxidative stress in mice","volume":"215","author":"Nemmar","year":"2015","journal-title":"Resp. Physiol. Neurobiol."},{"key":"10.1016\/j.biopha.2019.109652_bib0060","first-page":"28","article-title":"Effect of Shufeng Jiedu capsule on the fever caused by viral upper respiratory tract infection: a report of 130 cases","author":"Xi","year":"2010","journal-title":"J. Trandit. Chin. Med."},{"key":"10.1016\/j.biopha.2019.109652_bib0065","first-page":"234","article-title":"Pharmacodynamic study on antiviral and antibacterial effects of shufeng jiedu capsules in vitro","volume":"3","author":"Lv","year":"2013","journal-title":"Tradit. Chin. Drug Res. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109652_bib0070","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.biopha.2017.07.118","article-title":"Anti-inflammatory effects of Shufengjiedu capsule for upper respiratory infection via the ERK pathway","volume":"94","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.biopha.2019.109652_bib0075","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1021\/acs.jproteome.7b00409","article-title":"Therapeutic mechanistic studies of ShuFengJieDu capsule in an acute lung injury animal model using quantitative proteomics technology","volume":"16","author":"Tao","year":"2017","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.biopha.2019.109652_bib0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5582\/bst.8.45","article-title":"Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK\/NF-kappaB pathway","volume":"8","author":"Tao","year":"2014","journal-title":"Biosci. Trends"},{"issue":"2","key":"10.1016\/j.biopha.2019.109652_bib0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1159\/000494184","article-title":"Shufeng jiedu capsules alleviate lipopolysaccharide-induced acute lung inflammatory injury via activation of GPR18 by verbenalin","volume":"50","author":"Yuan","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2019.109652_bib0090","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1159\/000478754","article-title":"Emodin: one main ingredient of shufeng jiedu capsule reverses chemoresistance of lung cancer cells through inhibition of EMT","volume":"42","author":"Ying","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2019.109652_bib0095","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.biopha.2018.01.163","article-title":"Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma","volume":"99","author":"Xia","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.biopha.2019.109652_bib0100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/resp.12542","article-title":"Bronchial epithelial cells: the key effector cells in the pathogenesis of chronic obstructive pulmonary disease?","volume":"20","author":"Gao","year":"2015","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.biopha.2019.109652_bib0105","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMra074111","article-title":"Acute lower respiratory tract infection","volume":"358","author":"Mizgerd","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.109652_bib0110","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.immuni.2009.02.005","article-title":"The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA","volume":"30","author":"Allen","year":"2009","journal-title":"Immunity."},{"issue":"4","key":"10.1016\/j.biopha.2019.109652_bib0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2009.02.006","article-title":"The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1","volume":"30","author":"Thomas","year":"2009","journal-title":"Immunity."},{"issue":"3","key":"10.1016\/j.biopha.2019.109652_bib0120","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.pharmthera.2011.03.007","article-title":"The role of the NLRP3 inflammasome in the pathogenesis of airway disease","volume":"130","author":"Birrell","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2019.109652_bib0125","first-page":"183","article-title":"Well-differentiated human airway epithelial cell cultures","volume":"107","author":"Fulcher","year":"2005","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109652_bib0130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejphar.2010.09.056","article-title":"Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells","volume":"650","author":"Yamaya","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109652_bib0135","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7150\/jca.17205","article-title":"Combined targeting of mTOR and akt using rapamycin and MK-2206 in the treatment of tuberous sclerosis complex","volume":"8","author":"Ji","year":"2017","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2019.109652_bib0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1152\/jappl.1984.56.1.240","article-title":"Relationship of skin surface area to body mass in the immature rat: a reexamination","volume":"56","author":"Spiers","year":"1984","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.biopha.2019.109652_bib0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2017.03.002","article-title":"Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses","volume":"142","author":"Leyva-Grado","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2019.109652_bib0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.coph.2016.08.003","article-title":"Antiviral therapies on the horizon for influenza","volume":"30","author":"Naesens","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109652_bib0155","first-page":"395","article-title":"Clinical observation of Shufeng Jiedu Capsule in the treatment of acute exacerbation of chronic obstructive pulmonary disease with pulmonary infection","volume":"32","author":"Li","year":"2017","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2019.109652_bib0160","first-page":"347","article-title":"Curative effect evaluation of Shufeng Jiedu Capsules for the treatment of acute exacerbation of chronic obstructive pulmonary disease","volume":"32","author":"Yao","year":"2017","journal-title":"China J. Tradit. Chin. Med. and Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2019.109652_bib0165","first-page":"4227","article-title":"Clinical observation on Shufeng Jiedu Capsule combined with western medicine basic plan in treating acute exacerbations of chronic obstructive pulmonary disease with syndrome of wind-heat invading lung","volume":"33","author":"Zhu","year":"2018","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"key":"10.1016\/j.biopha.2019.109652_bib0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1142\/S0192415X0600359X","article-title":"Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: a self-control study","volume":"34","author":"Poon","year":"2006","journal-title":"Am. J. Chin. Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.109652_bib0175","first-page":"253","article-title":"Complementary and alternative medicine is expected to make greater contribution in controlling the prevalence of influenza","volume":"7","author":"Tao","year":"2013","journal-title":"Biosci. Trends"},{"issue":"105","key":"10.1016\/j.biopha.2019.109652_bib0180","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"issue":"7","key":"10.1016\/j.biopha.2019.109652_bib0185","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biopha.2019.109652_bib0190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.antiviral.2010.09.020","article-title":"Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model","volume":"88","author":"Bantia","year":"2010","journal-title":"Antiviral Res."},{"issue":"12","key":"10.1016\/j.biopha.2019.109652_bib0195","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S1473-3099(14)70821-7","article-title":"Antiviral combinations for severe influenza","volume":"14","author":"Dunning","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2019.109652_bib0200","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3389\/fphar.2018.01207","article-title":"Investigating different mechanisms of action in combination therapy for influenza","volume":"9","author":"Melville","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109652_bib0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00705-013-1807-3","article-title":"Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection","volume":"159","author":"Ohgitani","year":"2014","journal-title":"Arch. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109652_bib0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/135965350300800301","article-title":"Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza","volume":"8","author":"Ison","year":"2003","journal-title":"Antivir. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2019.109652_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000362","article-title":"Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial","volume":"7","author":"Duval","year":"2010","journal-title":"PLoS Med."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219352746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219352746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:04:47Z","timestamp":1778241887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219352746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":43,"alternative-id":["S0753332219352746"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109652","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 First Affiliated Hospital of Anhui Medical University. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109652"}}